A comparative study of cefotetan and metronidazole against metronidazole alone to prevent infection after appendectomy. 1987

R G Wilson, and E W Taylor, and G Lindsay, and C Dreghorn, and G Thompson, and J McGavigan, and F J Bone

The role of metronidazole in reducing the incidence of infectious complications after appendectomy has been established, but the value of an additional antibiotic to act against aerobic pathogens remains controversial. Patients who received 2 grams of cefotetan intravenously at the time of appendectomy and those who did not were compared for the incidence of infection. All patients received 1 gram of metronidazole per rectum preoperatively and every 12 hours for five days postoperatively. Infection occurred in three patients who received cefotetan and 16 of those who did not (p less than 0.01). We conclude that a single dose of cefotetan, an antibiotic which is effective against aerobic and anaerobic organisms, produces a significant reduction in the incidence of infection when added to metronidazole in the management of patients after appendectomy.

UI MeSH Term Description Entries
D008297 Male Males
D008795 Metronidazole A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. 2-Methyl-5-nitroimidazole-1-ethanol,Bayer 5360,Clont,Danizol,Flagyl,Gineflavir,Metric,MetroGel,Metrodzhil,Metrogyl,Metronidazole Hydrochloride,Metronidazole Monohydrochloride,Metronidazole Phosphate,Metronidazole Phosphoester,Satric,Trichazol,Trichopol,Trivazol,Vagilen,2 Methyl 5 nitroimidazole 1 ethanol
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002513 Cephamycins Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms. Antibiotics, Cephamycin,Cephamycin,Cephamycin Antibiotics
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli

Related Publications

R G Wilson, and E W Taylor, and G Lindsay, and C Dreghorn, and G Thompson, and J McGavigan, and F J Bone
July 1989, Surgery, gynecology & obstetrics,
R G Wilson, and E W Taylor, and G Lindsay, and C Dreghorn, and G Thompson, and J McGavigan, and F J Bone
October 1985, World journal of surgery,
R G Wilson, and E W Taylor, and G Lindsay, and C Dreghorn, and G Thompson, and J McGavigan, and F J Bone
February 1982, American journal of surgery,
R G Wilson, and E W Taylor, and G Lindsay, and C Dreghorn, and G Thompson, and J McGavigan, and F J Bone
August 1979, Ugeskrift for laeger,
R G Wilson, and E W Taylor, and G Lindsay, and C Dreghorn, and G Thompson, and J McGavigan, and F J Bone
July 1989, Journal of chemotherapy (Florence, Italy),
R G Wilson, and E W Taylor, and G Lindsay, and C Dreghorn, and G Thompson, and J McGavigan, and F J Bone
February 1987, Zhonghua wai ke za zhi [Chinese journal of surgery],
R G Wilson, and E W Taylor, and G Lindsay, and C Dreghorn, and G Thompson, and J McGavigan, and F J Bone
January 1985, Revista de gastroenterologia de Mexico,
R G Wilson, and E W Taylor, and G Lindsay, and C Dreghorn, and G Thompson, and J McGavigan, and F J Bone
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
R G Wilson, and E W Taylor, and G Lindsay, and C Dreghorn, and G Thompson, and J McGavigan, and F J Bone
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
R G Wilson, and E W Taylor, and G Lindsay, and C Dreghorn, and G Thompson, and J McGavigan, and F J Bone
February 1990, Journal of the Royal College of Surgeons of Edinburgh,
Copied contents to your clipboard!